Winner Medical(SZ:300888)2024-05-10 01:43Financial Performance - In 2023, the company achieved a total revenue of 8.19 billion CNY, a year-on-year decrease of 27.9% [1] - The net profit attributable to shareholders was 580 million CNY, with a decrease of 64.8% year-on-year [1] - Excluding non-recurring gains and losses, the net profit was 410 million CNY, down 73.6% [1] - The medical consumables business generated a revenue of 2.95 billion CNY, while the consumer goods business reached 4.26 billion CNY, with increases of 17.3% and 6.4% respectively [1] Business Strategy - The company emphasizes a dual focus on medical and consumer goods, aiming for synchronized development in both sectors [2] - The strategy includes maintaining product leadership and operational excellence, with a commitment to long-term and altruistic principles [2] - The company plans to continue expanding its brand presence in international markets, particularly in Europe and Southeast Asia [5] Product Development - Key product lines include surgical packs and high-end dressings, which are expected to maintain good growth throughout 2024 [3] - The company is focusing on innovation in the cotton towel category, with a projected growth rate of over 20% in Q1 2024 [4] - New product launches include biodegradable masks and hanging cotton towels, enhancing user experience and environmental sustainability [3][4] Market Positioning - The company has strengthened its brand recognition and channel development over the past three years, despite fluctuations due to public health events [2] - The company is actively addressing inventory issues related to pandemic products and is focusing on maintaining its market leadership in infection protection products [3] Future Outlook - The company anticipates a return to normalized production and sales operations starting in 2024, reducing significant performance fluctuations [2] - Plans for 2024 include opening approximately 100 new stores, primarily in first- and second-tier cities, while also exploring franchise opportunities in third- and fourth-tier cities [4] - The company aims to enhance its competitive edge through strategic acquisitions and investments in the medical consumables sector [5] Shareholder Returns - The company is committed to cash dividends, with the proportion of dividends relative to net profit increasing annually [7] - A dynamic balance will be maintained between shareholder returns and investment needs, adjusting dividend amounts based on investment opportunities [7]